CN107449904A - 一种自身免疫性糖尿病检测用反应膜条、制备和使用方法 - Google Patents
一种自身免疫性糖尿病检测用反应膜条、制备和使用方法 Download PDFInfo
- Publication number
- CN107449904A CN107449904A CN201710793219.5A CN201710793219A CN107449904A CN 107449904 A CN107449904 A CN 107449904A CN 201710793219 A CN201710793219 A CN 201710793219A CN 107449904 A CN107449904 A CN 107449904A
- Authority
- CN
- China
- Prior art keywords
- detection
- film bar
- coated
- diaphragm
- band
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 101
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 title claims abstract description 40
- 238000006243 chemical reaction Methods 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 238000001262 western blot Methods 0.000 claims abstract description 7
- 238000007689 inspection Methods 0.000 claims abstract description 6
- 239000000427 antigen Substances 0.000 claims description 56
- 108091007433 antigens Proteins 0.000 claims description 56
- 102000036639 antigens Human genes 0.000 claims description 56
- 239000000243 solution Substances 0.000 claims description 47
- 238000004140 cleaning Methods 0.000 claims description 19
- 239000012528 membrane Substances 0.000 claims description 16
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 102100030801 Elongation factor 1-alpha 1 Human genes 0.000 claims description 12
- 101000920078 Homo sapiens Elongation factor 1-alpha 1 Proteins 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- 239000004677 Nylon Substances 0.000 claims description 11
- 229920001778 nylon Polymers 0.000 claims description 11
- 101000761737 Homo sapiens Ubiquitin-conjugating enzyme E2 L3 Proteins 0.000 claims description 10
- 239000000020 Nitrocellulose Substances 0.000 claims description 10
- 102100024861 Ubiquitin-conjugating enzyme E2 L3 Human genes 0.000 claims description 10
- 229920001220 nitrocellulos Polymers 0.000 claims description 10
- 239000011248 coating agent Substances 0.000 claims description 9
- 238000000576 coating method Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000007853 buffer solution Substances 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 6
- 238000010521 absorption reaction Methods 0.000 claims description 5
- 239000000758 substrate Substances 0.000 claims description 4
- 238000012360 testing method Methods 0.000 claims description 4
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 claims description 3
- 241001494479 Pecora Species 0.000 claims description 3
- 239000000872 buffer Substances 0.000 claims description 3
- 238000011534 incubation Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000006386 neutralization reaction Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 10
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 2
- 230000007812 deficiency Effects 0.000 abstract description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- 102000008214 Glutamate decarboxylase Human genes 0.000 description 11
- 108091022930 Glutamate decarboxylase Proteins 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 201000010099 disease Diseases 0.000 description 10
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 7
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- 208000001921 latent autoimmune diabetes in adults Diseases 0.000 description 6
- 208000023275 Autoimmune disease Diseases 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 230000005784 autoimmunity Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 238000003119 immunoblot Methods 0.000 description 3
- 210000004153 islets of langerhan Anatomy 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 239000012898 sample dilution Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical group C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 2
- 101100278885 Arabidopsis thaliana E2FE gene Proteins 0.000 description 2
- 102100032378 Carboxypeptidase E Human genes 0.000 description 2
- 108010058255 Carboxypeptidase H Proteins 0.000 description 2
- 101000825079 Homo sapiens Transcription factor SOX-13 Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108010068204 Peptide Elongation Factors Proteins 0.000 description 2
- 102000002508 Peptide Elongation Factors Human genes 0.000 description 2
- 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 description 2
- 102100022435 Transcription factor SOX-13 Human genes 0.000 description 2
- 102000004248 Zinc Transporter 8 Human genes 0.000 description 2
- 108090000702 Zinc Transporter 8 Proteins 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 230000001363 autoimmune Effects 0.000 description 2
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003593 chromogenic compound Substances 0.000 description 2
- 238000003759 clinical diagnosis Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 108020000494 protein-tyrosine phosphatase Proteins 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000028387 Felty syndrome Diseases 0.000 description 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 108010076181 Proinsulin Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000006472 autoimmune response Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006058 immune tolerance Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000004412 neuroendocrine cell Anatomy 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710793219.5A CN107449904A (zh) | 2017-09-06 | 2017-09-06 | 一种自身免疫性糖尿病检测用反应膜条、制备和使用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710793219.5A CN107449904A (zh) | 2017-09-06 | 2017-09-06 | 一种自身免疫性糖尿病检测用反应膜条、制备和使用方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107449904A true CN107449904A (zh) | 2017-12-08 |
Family
ID=60495933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710793219.5A Pending CN107449904A (zh) | 2017-09-06 | 2017-09-06 | 一种自身免疫性糖尿病检测用反应膜条、制备和使用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107449904A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108152503A (zh) * | 2017-12-19 | 2018-06-12 | 上海澜帆实业有限公司 | 酶联免疫斑点印迹的自身免疫检测试剂盒及其操作流程 |
CN113138272A (zh) * | 2021-05-14 | 2021-07-20 | 南京医科大学附属逸夫医院 | 一种检测泛素结合酶抗体的试剂盒及使用方法 |
CN114184793A (zh) * | 2021-12-09 | 2022-03-15 | 深圳市亚辉龙生物科技股份有限公司 | 锌转运蛋白8抗体化学发光免疫检测试剂盒及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101042399A (zh) * | 2007-03-12 | 2007-09-26 | 深圳市伯劳特生物制品有限公司 | 糖尿病自身抗体免疫印迹试剂盒 |
CN101539579A (zh) * | 2009-04-28 | 2009-09-23 | 中国人民解放军第三军医大学第一附属医院 | 糖尿病自身抗体谱免疫印迹试剂盒 |
CN102967704A (zh) * | 2012-11-26 | 2013-03-13 | 深圳市伯劳特生物制品有限公司 | 一种用于糖尿病自身抗体6项联检试剂盒 |
CN103105489A (zh) * | 2013-01-23 | 2013-05-15 | 深圳市亚辉龙生物科技有限公司 | 检测自身免疫性疾病抗体的免疫印迹试剂盒及其制备方法 |
KR20160110865A (ko) * | 2015-03-13 | 2016-09-22 | 서울대학교산학협력단 | 자가항체를 이용한 제1형 당뇨병 진단방법 |
-
2017
- 2017-09-06 CN CN201710793219.5A patent/CN107449904A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101042399A (zh) * | 2007-03-12 | 2007-09-26 | 深圳市伯劳特生物制品有限公司 | 糖尿病自身抗体免疫印迹试剂盒 |
CN101539579A (zh) * | 2009-04-28 | 2009-09-23 | 中国人民解放军第三军医大学第一附属医院 | 糖尿病自身抗体谱免疫印迹试剂盒 |
CN102967704A (zh) * | 2012-11-26 | 2013-03-13 | 深圳市伯劳特生物制品有限公司 | 一种用于糖尿病自身抗体6项联检试剂盒 |
CN103105489A (zh) * | 2013-01-23 | 2013-05-15 | 深圳市亚辉龙生物科技有限公司 | 检测自身免疫性疾病抗体的免疫印迹试剂盒及其制备方法 |
KR20160110865A (ko) * | 2015-03-13 | 2016-09-22 | 서울대학교산학협력단 | 자가항체를 이용한 제1형 당뇨병 진단방법 |
Non-Patent Citations (1)
Title |
---|
肖倩等: "特发性1型糖尿病的发病机制进展", 《上海交通大学学报(医学版)》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108152503A (zh) * | 2017-12-19 | 2018-06-12 | 上海澜帆实业有限公司 | 酶联免疫斑点印迹的自身免疫检测试剂盒及其操作流程 |
CN113138272A (zh) * | 2021-05-14 | 2021-07-20 | 南京医科大学附属逸夫医院 | 一种检测泛素结合酶抗体的试剂盒及使用方法 |
CN114184793A (zh) * | 2021-12-09 | 2022-03-15 | 深圳市亚辉龙生物科技股份有限公司 | 锌转运蛋白8抗体化学发光免疫检测试剂盒及其制备方法 |
CN114184793B (zh) * | 2021-12-09 | 2023-08-11 | 深圳市亚辉龙生物科技股份有限公司 | 锌转运蛋白8抗体化学发光免疫检测试剂盒及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103105489B (zh) | 检测自身免疫性疾病抗体的免疫印迹试剂盒及其制备方法 | |
CN107022548B (zh) | 一种人体抗aqp4自身抗体检测材料及其制备方法 | |
CN105934671B (zh) | 用于评估妊娠糖尿病的方法和试剂 | |
CN107449904A (zh) | 一种自身免疫性糖尿病检测用反应膜条、制备和使用方法 | |
Nakama et al. | Evaluation of the optimum cut-off point in immunochemical occult blood testing in screening for colorectal cancer | |
CN107688090A (zh) | 一种NTx检测试纸、试剂盒及其制备方法 | |
EP2145899A1 (en) | RS virus detecting kit using anti-RS virus monoclonal antibody, immuno-chromatographic test device, and new anti-RS virus monoclonal antibody | |
CN111239421A (zh) | 一种定量检测脂联素adpn的胶乳增强免疫比浊试剂盒及其制备与应用方法 | |
CN106053812A (zh) | 一种用于肝癌早期筛查和诊断的多种自身抗体联合检测elisa试剂盒 | |
CN102967704B (zh) | 一种用于糖尿病自身抗体6项联检试剂盒 | |
CN104119440B (zh) | 针对胱抑素c的单克隆抗体、杂交瘤细胞株制备及其用途 | |
CN107045062A (zh) | 检测人ngal的胶体金免疫层析试纸条、试剂盒及其制备方法 | |
CN110361442A (zh) | 一种用于质谱流式细胞仪检测的外泌体及其制备方法与应用 | |
CN108196061B (zh) | 一种基于单克隆抗体检测人pgrn的双夹心elisa试剂盒 | |
US10228373B2 (en) | Kit and method for diagnosis, prognosis or monitoring of liver disease through measurement of amount of AST | |
CN105823873A (zh) | 检测自身免疫性肾病的免疫印迹试剂盒及其制备方法 | |
CN103543272A (zh) | 同时检测心型脂肪酸结合蛋白和肌钙蛋白i的快速定量检测装置及检测方法 | |
CN107271692A (zh) | 一种标记特异性高亲和力重组抗体的荧光微球及其应用 | |
CN103529224B (zh) | 同时检测人脑钠肽和n末端脑钠肽前体的快速定量检测装置及检测方法 | |
CN110346576A (zh) | 一种抗原固定化基质膜及包含其的用于检测自身免疫疾病相关抗核抗体谱的试剂盒及其用途 | |
CN104569419B (zh) | 一种检测人血液glp-1总含量的化学发光免疫分析法试剂盒 | |
CN108918876A (zh) | 一种联合定量检测尿液微量白蛋白和胱抑素c的试纸条 | |
CN103630692B (zh) | 快速检测尿液c肽的胶体金免疫层析试剂盒及其检测方法 | |
CN203191382U (zh) | 一种检测多种抗核抗体的免疫印迹试剂盒 | |
KR20100078827A (ko) | 유방암 진단용 빈쿨린 자가항체 및 이를 이용한 진단키트 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Hu Kunhui Inventor after: Liu Yao Inventor after: Lin Jun Inventor after: Zheng Yanping Inventor after: Wang Dongkai Inventor before: Hu Kunhui Inventor before: Wang Dongkai Inventor before: Liu Yao Inventor before: Lin Jun Inventor before: Zheng Yanping |
|
CB03 | Change of inventor or designer information | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171208 |
|
RJ01 | Rejection of invention patent application after publication |